SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-010586
Filing Date
2023-04-19
Accepted
2023-04-19 06:19:59
Documents
14
Period of Report
2023-04-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20230418_8k.htm   iXBRL 8-K 28309
2 EXHIBIT 17.1 ex_502471.htm EX-17.1 2992
  Complete submission text file 0001437749-23-010586.txt   168936

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wint-20230418.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20230418_def.xml EX-101.DEF 11920
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20230418_lab.xml EX-101.LAB 15967
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20230418_pre.xml EX-101.PRE 12131
8 EXTRACTED XBRL INSTANCE DOCUMENT wint20230418_8k_htm.xml XML 2652
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 23828422
SIC: 2836 Biological Products, (No Diagnostic Substances)